STOCK TITAN

ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 1:20 p.m. EDT. The chat will be available via a live video webcast, with a replay accessible approximately 12 hours after the event, remaining available until June 8, 2022. ResMed focuses on innovative health solutions for chronic diseases, aiming to improve quality of life and lower healthcare costs globally.

Positive
  • Participation in reputable Goldman Sachs healthcare conference highlights the company's visibility in the healthcare sector.
  • Focus on digital health technologies could position ResMed for growth in a rapidly evolving healthcare landscape.
Negative
  • None.

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginning at approximately 1:20 p.m. (Eastern Daylight Time) via video webcast.

More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 12 hours after the live webcast ends and will be accessible through June 8, 2022.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investorsFor media
Amy WakehamJayme Rubenstein
+1 858.836.5000+1 858.836.6798
investorrelations@resmed.comnews@resmed.com

FAQ

When is ResMed's virtual fireside chat at the Goldman Sachs conference?

ResMed's virtual fireside chat is on June 8, 2021, at 1:20 p.m. EDT.

Who will represent ResMed at the Goldman Sachs conference?

Rob Douglas, president and COO, will represent ResMed at the conference.

How can I access the live webcast of ResMed's presentation?

The live webcast can be accessed through ResMed's investor relations website.

Will there be a replay available for ResMed's presentation?

Yes, a replay will be available approximately 12 hours after the live event and accessible until June 8, 2022.

ResMed Inc.

NYSE:RMD

RMD Rankings

RMD Latest News

RMD Stock Data

35.79B
145.66M
0.77%
61.33%
5.38%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SAN DIEGO